FUNGAL LABORATORY DIAGNOSIS OF CLINICAL SPECIMEN    

Authors : Gautam Panwar; Swarnima Singh; Sobhit

Publishing Date : 2023

DOI : https://doi.org/10.52458/9789388996846.nsp2023.eb.ch-13

ISBN : 978-93-88996-97-6

Pages : 93

Chapter id : GU/NSP/EB/CMDT/2023/Ch-13

Abstract : This book chapter, titled "Fungal Laboratory Diagnosis of Clinical Specimens," offers a comprehensive exploration of fungal infections and the crucial role of laboratory diagnostics in their detection and management. It provides insights into the diverse spectrum of fungal infections, their epidemiology, clinical significance, and the varying clinical manifestations across different patient populations. The chapter details the procedures for proper specimen collection and handling, direct microscopic examination, culture techniques, and the utilization of advanced molecular and serological methods for accurate fungal identification. It also delves into antifungal susceptibility testing and emphasizes the importance of quality control and adherence to regulatory standards in clinical laboratories. Furthermore, the chapter discusses emerging trends and advances in the field of fungal diagnostics, highlighting both challenges and opportunities. Throughout, it underscores the essential collaboration between laboratory professionals and clinicians in ensuring accurate diagnosis and optimal patient care.

Keywords : Fungal Infections, Laboratory Diagnosis of Fungal Infections, Fungal Culture Techniques, Antifungal Susceptibility Testing

Cite : Panwar, G., Singh, S., & S. (2023). Fungal Laboratory Diagnosis Of Clinical Specimen (1st ed., p. 93). Noble Science Press. https://doi.org/10.52458/9789388996846.nsp2023.eb.ch-13

References :

1. Abbott, S. L., & Janda, J. M. (1994). Fungal identification by automated PLEX-ID PCR–electrospray ionization mass spectrometry. Journal of Clinical Microbiology, 52(7), 2302-2305.
2. Anaissie, E. J., & McGinnis, M. R. (2013). Clinical mycology. Elsevier.
3. Balajee, S. A., & Marr, K. A. (2006). Molecular epidemiology of Aspergillus species in an antifungal-experienced patient population. Clinical Infectious Diseases, 42(2), 159-167.
4. Brewer, J. H. (2018). How to perform fungal cultures from blood and other sterile body fluids. Mycopathologia, 183(1), 7-18.
5. Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., & White, T. C. (2012). Hidden killers: human fungal infections. Science translational medicine, 4(165), 165rv13.
6. Clinical and Laboratory Standards Institute (CLSI). (2017). Reference method for broth dilution antifungal susceptibility testing of yeasts (M27-4). CLSI.
7. Clinical and Laboratory Standards Institute (CLSI). (2018). Method for antifungal disk diffusion susceptibility testing of nonfermentative yeasts; approved guideline—second edition (M51-A2). CLSI.
8. Clinical and Laboratory Standards Institute (CLSI). (2018). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard—third edition (M38-A3). CLSI.
9. de Hoog, G. S., Guarro, J., Gene, J., & Figueras, M. J. (2012). Atlas of clinical fungi (2nd ed.). Centraalbureau voor Schimmelcultures.
10. Ghosh, A., & Khan, M. (2014). Recent trends in the molecular diagnosis of dermatophytosis. BioMed Research International, 2014.
11. Guinea, J., & Peláez, T. (2017). Recurrent candidemia and breakthrough candidemia in a tertiary medical centre. Mycoses, 60(6), 335-339.
12. Hall, L., & Wohlfiel, S. L. (2011). The role of culture and nucleic acid amplification tests in diagnosing fungal infections. Expert Review of Molecular Diagnostics, 11(3), 297-306.
13. Hazen, K. C. (2017). New and emerging yeast pathogens. Clinical Microbiology Reviews, 30(1), 1-26.
14. Irinyi, L., Serena, C., Garcia-Hermoso, D., Arabatzis, M., Desnos-Ollivier, M., Vu, D., ... & Meyer, W. (2015). International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Medical Mycology, 53(4), 313-337.
15. Kauffman, C. A. (2015). Fungal infections. Proceedings of the American Thoracic Society, 12(3), 169-172.
16. Kauffman, C. A., & Malani, A. N. (2007). Zygomycosis: An emerging fungal infection with new options for management. Current Infectious Disease Reports, 9(6), 435-440.
17. Kojic, E. M., Darouiche, R. O., Abi-Said, D., & Pappas, P. G. (2002). Fungal prosthetic valve endocarditis in patients with candidemia: case report and review. Clinical Infectious Diseases, 34(7), 949-953.
18. Kuper, K. M., Slagle, D. C., & Turpin, B. (2016). Fungal infections: Diagnosis and management. Critical Care Nursing Clinics of North America, 28(3), 259-273.
19. Larone, D. H. (2011). Medically important fungi: A guide to identification (5th ed.). American Society for Microbiology
20. Larone, D. H. (2011). Medically important fungi: A guide to identification (5th ed.). American Society for Microbiology.
21. Leiva, L. E., Moncada, L. H., & Vélez, H. (2002). Clinical application of an enzyme immunoassay for diagnosis of tegumentary and visceral leishmaniasis. Clinical and Vaccine Immunology, 9(6), 1390-1395.
22. Marr, K. A., & Bowden, R. A. (2005). Clinical fungal infections in transplant patients. Transplant Infectious Disease, 7(3?4), 115-125.
23. Morrell, M., & Fraser, V. J. (2005). Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Critical Care Medicine, 33(7), 1249-1255
24. Nenoff, P., Erhard, M., Simon, J. C., Muylowa, G. K., Yankova, R., & Wetzig, T. (2014). Microsporum canis as a causative agent of tinea corporis /faciei: Comparative investigation of clinical isolates and a reference strain. Mycoses, 57(2), 73-82.
25. Pappas, P. G., & Alexander, B. D. (2005). Invasive fungal infections in the intensive care unit. Seminars in respiratory and critical care medicine, 26(3), 305-321.
26. Patterson, T. F. (2010). Advances and challenges in management of invasive mycoses. The Lancet, 375(9717), 1484-1492.
27. Perfect, J. R. (2017). Clinical manifestations of fungal infections. Cold Spring Harbor Perspectives in Medicine, 5(4), a019687.
28. Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., ... & Stevens, D. A. (2010). Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 50(3), 291-322.
29. Pfaller, M. A., & Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clinical microbiology reviews, 20(1), 133-163.
30. Pfaller, M. A., & Diekema, D. J. (2012). Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. Journal of Clinical Microbiology, 50(9), 2846-2856.
31. Richardson, M. D., & Warnock, D. W. (2012). Fungal infection: diagnosis and management (4th ed.). John Wiley & Sons.
32. Rippon, J. W. (1988). Medical mycology: the pathogenic fungi and the pathogenic actinomycetes (3rd ed.). W.B. Saunders Company.
33. Schabereiter-Gurtner, C., Selitsch, B., Rotter, M. L., Hirschl, A. M., & Willinger, B. (2007). Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. Journal of clinical microbiology, 45(3), 906-914.
34. Thompson, G. R., & Wiederhold, N. P. (2017). Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia, 182(1-2), 191-200.
35. Wheat, L. J., & Azar, M. M. (2006). Histoplasmosis. Infectious Disease Clinics, 20(3), 609-631.
36. White, T. J., Bruns, T., Lee, S., & Taylor, J. W. (1990). Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications, 18(1), 315-322.